CoLucid Pharmaceuticals Garners $4,750,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=da39a8d6-8685-439f-b3a2-3155d1169880
Date
7/12/2013
Company Name
CoLucid Pharmaceuticals
Mailing Address
P.O. Box 14401 Durham, NC 27709 USA
Company Description
CoLucid Pharmaceuticals is an innovative biotechnology company focusing on therapies for central nervous system (CNS) disorders. CoLucid is leading a paradigm shift in migraine therapy with the clinical development of a first-in-class Neurally Acting Anti-Migraine Agent (NAAMA).
Website
http://www.colucid.com
Transaction Type
Debt
Transaction Amount
$4,750,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing.
M&A Terms
Venture Investor